China NT Pharma and Hilong raise a combined $342 million

Investors respond well to the Hong Kong IPOs of China NT Pharma and Hilong, helping them to raise a total of $342 million.

China NT Pharma and Hilong raise a combined $342 million
China NT Pharma's Suzhou factory

China NT Pharma Group raised HK$1.62 billion $208 million in a Hong Kong IPO last week, while Hilong Holdings pocketed HK$1.04 billion $134 million after a failed first attempt.

Both companies priced their shares at a discount to industrial peers. NT Pharma, a Shanghai-based supply chain and sales service provider for vaccines, sold 357 million shares at HK$4.54 each, the bottom end of an indicated price range that went up to...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES